A leading distributor of world-class genetic and esoteric laboratory investigations across Egypt and the MENA region, empowering clinicians with clarity, speed, and scientific precision.
At MASS Diagnostics, we are not just a medical service provider. We are your committed ally in advancing healthcare.
With a proud legacy of excellence and innovation, we continually strive to elevate the standards of medical care across Egypt and beyond. As a distributor of esteemed laboratories from around the globe, we are privileged to bring you the latest advancements in genetic and esoteric lab investigations.
Our collaborations with these universal laboratories empower us to deliver cutting-edge solutions that empower healthcare professionals and positively impact patient outcomes. We understand the critical role that accurate diagnostics play in patient care, and it is our unwavering commitment to provide you with the highest quality services and technologies.
Through our state-of-the-art facilities, expert team, and rigorous quality standards, we ensure that every test result is not just a number, but a beacon of hope and clarity for patients and clinicians alike.
Together, let us continue to push the boundaries of healthcare, foster innovation, and make a meaningful difference in the lives of those we serve.
Mass Diagnostics is a well-established company founded in 2018 by a team of highly qualified, skilled, and determined professionals, driven by a single purpose: to set an outstanding trend in genetics solutions across Egypt and the MENA region.
We are a duly registered private company, fully compliant with the Ministry of Health instructions in Egypt. Our well-designed system and professional staff serve clients to their full satisfaction.
As a trusted distributor of globally esteemed laboratories, Mass Diagnostics bridges the gap between world-class genetic testing capabilities and the patients and clinicians who need them most, transforming complex diagnostic results into actionable insights that change lives.
More than 2.8 million individuals across the region are living with rare conditions, creating a critical need for advanced genetic diagnostics.
Delayed diagnosis remains a major barrier to timely care, appropriate treatment selection, and family guidance.
Most rare diseases have a genetic origin, making precise DNA testing essential for clear and actionable clinical decisions.
Regional consanguinity rates contribute to higher prevalence, reinforcing the value of accessible inherited disease testing.
Egypt has achieved strong newborn screening coverage, with 469,805 newborns screened through the 100 Million Health campaign.
Dedicated treatment centers support Egypt's momentum in rare disease care and national health system advancement.
The regional genetic testing market reflects strong demand for accessible, specialized diagnostic capabilities.
Growth across the Middle East and Africa creates a timely opportunity for trusted diagnostic partners.
Solutions for undiagnosed conditions across 14+ specialties, including single-gene and multi-gene panels, WES, and WGS.
Carrier screening, non-invasive prenatal testing, and prenatal diagnosis for high-risk pregnancies.
Hereditary cancer panels, tumor profiling, and pharmacogenomics support for precision oncology pathways.
Newborn screening panels and inborn errors of metabolism investigations for early clinical action.
Chromosome analysis, FISH, and microarray testing for structural abnormalities and complex genetic cases.
Our commitment to regulatory excellence and diagnostic clarity connects disciplined sample handling with advanced sequencing, expert interpretation, and clear clinical reporting.
Rigorous collection standards and logistics protocols.
Access to global NGS and molecular diagnostic technologies.
Expert-curated, AI-supported insights for WES and WGS.
Human validation to support responsible interpretation.
Unambiguous reports that give clinicians and patients clarity.
Compliant with Egypt Ministry of Health instructions and operating as a registered private company.
Partner network includes CAP, CLIA, ISO-certified partners, Blueprint Genetics quality frameworks, and 3billion's California-licensed, KOSDAQ-listed capabilities.
To facilitate access to rare genetic disease testing across all Egyptian regions for healthier and safer generations ahead. We make a meaningful impact in healthcare by helping doctors and medical researchers obtain more accurate diagnoses and find appropriate treatment protocols, leading to real improvement in individuals' health worldwide.
To extend our arms throughout the Middle East by positioning ourselves as a leading laboratory partner across Europe and Asia. We strive to be at the top of the field by providing the most reliable and efficient diagnostic support, making world-class genetic testing accessible to every patient who needs it.
The principles that guide every decision, every interaction, and every result we deliver.
Every decision guided by the highest ethical standards, fostering trust and transparency in all we do.
Creativity fuels our evolution. We actively embrace change and drive continuous improvement.
Deep passion in understanding client needs, providing services that exceed expectations.
We listen actively, collaborate genuinely, and celebrate individual contributions at every level.
We prioritize balance because fulfilled team members drive truly exceptional results.
Dedicated to continuous development, empowering our team to unlock their full potential.
We proudly collaborate with leading genetic testing laboratories worldwide.
Committed to providing fast and accurate genetic diagnoses for rare disease patients, known for innovation and exceptional patient care.
Specializes in advanced PCR and RT-PCR diagnostic kits and DNA isolation kits, trusted in molecular biology research.
Dedicated to comprehensive, high-quality, rapid-response testing and integration of advanced technologies into patient care.
Focused on inherited diseases, delivering high-quality genetic testing solutions that inform clinical decision-making worldwide.
Contributing to national health and wellness through the advancement of laboratory medicine and comprehensive medical services.
Advanced genetic testing lab providing high-precision diagnostics and personalized genomic insights.
Deep knowledge of Egypt's healthcare landscape with access to world-class international laboratory partners.
Regional logistics and streamlined workflows support faster diagnosis for patients and providers.
Strategic partnerships make advanced genetic testing more accessible to Egyptian providers and patients.
Full-cycle guidance from test selection and sample logistics to result interpretation and counseling support.
Supporting Egypt's 100 Million Health and Digital Egypt 2030 initiatives through advanced diagnostics.
Enabling accurate diagnosis, appropriate treatment, and improved patient outcomes through precision medicine.
Extend services to underserved regions and governorates, ensuring equitable access to genetic diagnostics across Egypt and supporting integration with universal health insurance pathways.
Position Mass Diagnostics as a leading laboratory partner gateway for the broader MENA region while strengthening collaboration with Europe and Asia markets.
Integrate AI-powered diagnostic tools, expand whole-genome sequencing offerings, and adopt long-read sequencing technologies as clinical needs evolve.
Support Egypt's planned national rare disease registry, contribute to population genomics research, and enable digital health platforms for remote communities.
٦ شارع الطيران، النزهة، القاهرة
أعلى صيدلية الزهراء، الدور الرابع، عمارة الأندلس
6 El-Tayaran Street, El-Nozha, Cairo, Egypt.
Above El-Zahraa Pharmacy, 4th Floor, El-Andalus Building.
Near El-Gesr Metro Station.
٦ شارع الطيار محمود شكري - سموحة
برج الزهراء - الدور الثاني، الإسكندرية
6 El-Tayar Mahmoud Shokri St.,
Smouha, El-Zahraa Tower, 2nd Floor, Alexandria
